GlaxoSmithKline Plc - Company Snapshot & SWOT Analysis

March 2019 | 30 pages | ID: GC926AD3535EN
NAVADHI Market Research Pvt Ltd

Abstracts

GlaxoSmithKline (GSK) is a global pharmaceutical and consumer health products company and is headquartered in Brentford, the UK. The company operates in more than 100 countries and has a strong presence in US, Europe and Asia-Pacific.

GSK is looking forward to expanding its product portfolio and is investing heavily on Research and development for the same. The company has 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.

GlaxoSmithKline reported revenue of USD 40.992 billion for the FY 2018 which saw an increase of 4.46% compared to FY 2017. Consumer healthcare division had second largest revenue share with 24.85% revenue share. This division saw an increase of 1.09% compared to FY 2017 revenue.

GlaxoSmithKline registered highest revenue from respiratory (Seretide/ Advair, Ellipta Products (Anoro Ellipta, Arnuity Ellipta, Incruse Ellipta, Relvar/ Breo Ellipta, Trelegy Ellipta), Nucala/ Mepolizumab, Avamys/ Veramyst, Flixotide/ Flovent, Ventolin and Other) at USD 9.214 billion which accounted for 40.12% of its total pharmaceuticals sales in FY 2018.

Spanning over 29 pages and 10 exhibits, “GlaxoSmithKline Plc - Company Snapshot & SWOT Analysis” report provides value chain analysis, financial performance, business strategy and SWOT analysis for company.

Scope of the GlaxoSmithKline Plc- Company Snapshot & SWOT Analysis Report

• This report provides detailed information about GlaxoSmithKline Plc including value chain analysis, financial performance, business strategy and SWOT analysis.
• The report identifies the growth drivers and inhibitors for global pharmaceutical market.
• This report provides information about current and future trends for global pharmaceutical market.

Contents

1. EXECUTIVE SUMMARY

Scope of the GlaxoSmithKline Plc - Company Snapshot & SWOT Analysis Report
Research Methodology

2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET

3. COMPANY PROFILE

3.1 GlaxoSmithKline Plc
  3.1.1 Company Profile
  3.1.2 GlaxoSmithKline Plc in Global Pharmaceuticals Manufacturing Value Chain
  3.1.3 GlaxoSmithKline Plc: Financial Performance
    3.1.3.1 GlaxoSmithKline Plc: Overall Revenue FY 2013-FY 2019 (in USD billion)
    3.1.3.2 GlaxoSmithKline Plc: Division-Wise Revenue FY 2018 (in USD billion)
    3.1.3.3 GlaxoSmithKline Plc: Geography-Wise Revenue FY 2018 (in USD billion)
    3.1.3.4 GlaxoSmithKline Plc: Therapy Area-Wise Revenue FY 2018 (in USD billion)
  3.1.4 GlaxoSmithKline Plc: Business Strategy
    3.1.4.1 Product Level Strategy
  3.1.5 SWOT Analysis of GlaxoSmithKline Plc
Strengths
Weaknesses
Opportunities
Threats

4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET

Company Information

List Of Exhibits

LIST OF EXHIBITS

Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
Exhibit 3.1 Key information of GlaxoSmithKline Plc
Exhibit 3.2 Contact Information GlaxoSmithKline Plc
Exhibit 3.3 GlaxoSmithKline Plc in Pharmaceuticals Manufacturing Value Chain
Exhibit 3.4 Revenue of GlaxoSmithKline Plc FY 2013- FY 2019 (in USD billion)
Exhibit 3.5 Revenue Growth of GlaxoSmithKline Plc FY 2014- FY 2019 (in %)
Exhibit 3.6 Division-Wise Revenue of GlaxoSmithKline Plc in FY 2018 (in USD billion)
Exhibit 3.7 Pharmaceuticals Division Revenue of GlaxoSmithKline FY 2013- FY 2018 (in USD billion)
Exhibit 3.8 Vaccines Division Revenue of GlaxoSmithKline FY 2013- FY 2018 (in USD billion)
Exhibit 3.9 Consumer Healthcare Division Revenue of GlaxoSmithKline FY 2013- FY 2018 (in USD billion)
Exhibit 3.10 Geography-Wise Revenue of GlaxoSmithKline in FY 2018 (in USD billion)
Exhibit 3.11 Therapy Area-Wise Revenue of GlaxoSmithKline in FY 2018 (in USD billion)
Exhibit 3.12 Therapy and Geography Area-Wise Revenue of GlaxoSmithKline FY 2018 (in USD billion)
Exhibit 3.13 SWOT Analysis of GlaxoSmithKline Plc